Abstract CT233: Phase Ib/II study of leronlimab (PRO 140) combined with carboplatin in CCR5+ mTNBC patients
暂无分享，去创建一个
H. Rui | M. Cristofanilli | J. Lalezari | B. Patterson | M. Dolezal | Cha-Mei Tang | K. Kazempour | Qiang Zhang | K. Dhody | N. Pourhassan | D. Adams | N. Rabb